相关实验视频
Updated: Jul 2, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.2K
慢性疹症中的亚托皮:一个重要的,但被忽视的问题
Qiquan Chen1, Xianjie Yang1,2, Bing Ni3
1Department of Dermatology, Southwest Hospital, Army Medical University, Chongqing, China.
Frontiers in immunology
|February 21, 2024
概括
对过敏原的免疫反应 - - Atopy - - 在慢性疹 (CU) 中越来越多地被发现. 这篇评论探讨了阿托皮症.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 过敏 过敏是一种过敏.
背景情况:
- 慢性疹 (CU) 显著影响患者的生活质量,但其致病性尚未完全理解.
- 虽然在慢性自发性疹症 (CSU) 中研究了自身免疫力,但在CU 中对亚托皮的作用往往被忽视.
- 在CU患者中,特征为对过敏原的免疫反应,2型炎症和IgE过度产生的Atopy普遍存在.
研究的目的:
- 审查当前关于阿托皮和慢性疹病之间的关联的知识.
- 探索亚托皮在各种CU亚型的发病过程中的潜在作用.
- 为了解CU临床特征提供新的视角,并指导未来的研究.
主要方法:
- 对调查慢性疹症中阿托皮的研究的文献综述.
- 对亚托皮背景和CU临床特征之间的相关性进行分析.
- 在CU患者中检查IgE水平和炎症标志物,有和没有阿托皮.
主要成果:
- 与健康个体相比,患有CU的患者表现出较高的阿托皮患病率.
- 在CU患者中观察到总IgE水平升高,与疾病特征相关.
- 有证据表明,局部和全身的亚托皮性炎症有助于CU的发病.
结论:
- 性是慢性疹的一个重要因素,可能定义特定的CU亚型 (例如,性CSU,性CIndU).
- 对阿托皮的作用进行进一步的研究对于全面了解CU病变的产生至关重要.
- 识别阿托皮症为CU的临床表现和管理提供了新的见解.
相关概念视频
Allergic Reactions
27.4K
Overview
27.4K
Hypersensitivities
642
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
642
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
398
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
398
Antiasthma Drugs: Leukotriene Modifiers
298
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
298
Allergic Drug Reactions
842
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
842

